Key Market Indicator:
Ad-hoc news is mandatory information from listed companies that must be made available to investors. Depending on the occasion and content of the news, it can have an impact on the share price. The newsfeed covers a wide range of topics relevant to investor relations and is recommended as an important source of information before making an investment decision.
Wed, 22.01.2025
SNP Schneider-Neureither & Partner SE
SNP: Receipt of a notice of intention to enter into a domination and profit and loss transfer agreement between SNP Schneider-Neureither & Partner SE and Succession German Bidco GmbH
Heidelberg, Germany, 22 January 2025 – Today, SNP Schneider-Neureither & Partner SE (ISIN: DE0007203705, Prime Standard, Ticker Symbol: SHF) ("SNP" or the "Co [ … ]
Wed, 22.01.2025
SKAN AG
Ad hoc announcement pursuant to Art. 53 LR
SKAN announces preliminary key figures for the 2024 financial year
Allschwil, 22 January 2025 – The SKAN Group AG, world market leader for high-quality isolator systems for aseptic production processes in the (bio-) pharmaceutical industry, expects based on preliminary, not yet audited figures net sales [ … ]
Wed, 22.01.2025
Reinet Investments SCA
Reinet Investments S.C.A.’s wholly-owned subsidiary, Reinet Fund S.C.A., F.I.S., has today announced its net asset value as at 31 December 2024 as follows:
Quote
Reinet Fund S.C.A., F.I.S. (‘Reinet Fund’)
Net asset value per share as at 31 December 2024
As at 31 December 2024, the net asset value (‘NAV’) per share of Reinet Fund amounted to € 4 [ … ]
Wed, 22.01.2025
Relief Therapeutics Holding SA
Relief Therapeutics Completes Strategic Transition with Sale of GOLIKE® Rights ex-USSale of GOLIKE® Rights Outside the U.S. to Nutrisens
Relief to Focus on R&D of Pipeline Assets and Licensing for Commercialized Products
GENEVA (JAN. 22, 2025) – RELIEF THERAPEUTICS Holding SA (SIX: RLF, OTCQB: RLFTF, RLFTY) (Relief, or the Company), a biopharm [ … ]
Tue, 21.01.2025
Schaeffler AG
Disclosure of an inside information according to Article 17 MAR of the Regulation (EU) No 596/2014
Schaeffler AG: Based on preliminary figures, EBIT margin before special items for fiscal year 2024 below group guidance
Herzogenaurach, 21 January 2025 – Schaeffler AG (DE000SHA0019) releases results for fiscal year 2024 based on preliminary and [ … ]
Tue, 21.01.2025
adidas AG
FOR IMMEDIATE RELEASEHerzogenaurach, January 21, 2025
adidas finishes successful year with better-than-expected fourth quarter results
adidas today announced preliminary results for the fourth quarter of 2024. In Q4, currency-neutral revenues increased 19%. In euro terms, the company’s revenues grew 24% to € 5,965 million (2023: € 4,812 million). [ … ]
Tue, 21.01.2025
MEDICLIN AG
Offenburg, 21 January 2025
MEDICLIN raises full-year guidance for the 2024 financial year
MEDICLIN Aktiengesellschaft (Ticker: MED) announces that it is raising its guidance for the 2024 financial year.
Instead of a Group EBIT* between EUR 33.0 and 39.0 million, MEDICLIN now expects a Group EBIT between EUR 48.0 and 54.0 million. The sales forecast [ … ]
Tue, 21.01.2025
PPC Zeus Designated Activity Company
21 January 2025
THIS NOTICE IS IMPORTANT AND REQUIRES THE IMMEDIATE ATTENTION OF SENIOR NOTEHOLDERS. IF SENIOR NOTEHOLDERS ARE IN ANY DOUBT AS TO THE ACTION THEY SHOULD TAKE, THEY SHOULD IMMEDIATELY CONSULT THEIR OWN INDEPENDENT PROFESSIONAL ADVISERS AUTHORISED UNDER THE FINANCIAL SERVICES AND MARKETS ACT 2000, AS AMENDED (IF THEY ARE LOCATED I [ … ]
Tue, 21.01.2025
STEICO SE
STEICO SE: Changes to the Administrative Board
Feldkirchen near Munich, 21 January 2025 - (ISIN DE000A0LR936) - Mr Udo Schramek (Deputy Chairman of the Administrative Board) and Mrs Katarzyna Schramek today resigned from their positions as members of the Administrative Board of STEICO SE with effect from the end of 28 February 2025. The Administra [ … ]
Tue, 21.01.2025
IONOS Group SE
Karlsruhe / Berlin, 21 January 2025. The Management Board of IONOS Group SE resolved to launch a share buyback program and to acquire up to 1,500,000 treasury shares (corresponding to approx. 1.1% of the share capital of EUR 140,000,000) via the stock exchange. The volume of the buyback program amounts to a total of up to EUR 40 million (excluding [ … ]